The PPAR-gamma agonist pioglitazone post-transcriptionally induces p21 in PC3 prostate cancer but not in other cell lines
- PMID: 15738655
The PPAR-gamma agonist pioglitazone post-transcriptionally induces p21 in PC3 prostate cancer but not in other cell lines
Abstract
The anti-diabetic thiozolidinedione compound pioglitazone, a peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist, has been found to have growth inhibitory effects in some cancer cells. The mechanism underlying this growth suppression is not well understood. In this study, we evaluated the effect of pioglitazone on p53 and p21 expression in various cancer cell lines with different p53 status. The cells with wild type p53 did not show any change in p53 levels in response to pioglitazone. Also, none of the cell lines exhibited p53-dependent or independent transcriptional induction of p21(WAF1/CIP1) by pioglitazone. However, PC3, an androgen-insensitive prostate cancer cell line with deletion of p53 showed an appreciable post-transcriptional induction of p21 expression after treatment with pioglitazone. These results imply that pioglitazone generally does not modulate p21 transcription in human cancer cell lines.
Similar articles
-
RXR antagonism induces G0 /G1 cell cycle arrest and ameliorates obesity by up-regulating the p53-p21(Cip1) pathway in adipocytes.J Pathol. 2012 Apr;226(5):784-95. doi: 10.1002/path.3001. Epub 2012 Feb 9. J Pathol. 2012. PMID: 21956786
-
Indole-3-carbinol mediated cell cycle arrest of LNCaP human prostate cancer cells requires the induced production of activated p53 tumor suppressor protein.Biochem Pharmacol. 2006 Dec 15;72(12):1714-23. doi: 10.1016/j.bcp.2006.08.012. Epub 2006 Sep 12. Biochem Pharmacol. 2006. PMID: 16970927
-
Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.Int J Cancer. 2003 Nov 20;107(4):603-11. doi: 10.1002/ijc.11316. Int J Cancer. 2003. PMID: 14520699
-
Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist, Suppresses Rat Prostate Carcinogenesis.Int J Mol Sci. 2016 Dec 10;17(12):2071. doi: 10.3390/ijms17122071. Int J Mol Sci. 2016. PMID: 27973395 Free PMC article.
-
Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21(CIP1) in HepG2 human hepatoma cells.Mol Cancer Ther. 2004 Mar;3(3):309-16. Mol Cancer Ther. 2004. PMID: 15026551
Cited by
-
Pioglitazone and Prostate Cancer Risk in Taiwanese Male Patients with Type 2 Diabetes: A Retrospective Cohort Study.World J Mens Health. 2023 Jan;41(1):119-128. doi: 10.5534/wjmh.210157. Epub 2022 Mar 2. World J Mens Health. 2023. PMID: 35274506 Free PMC article.
-
The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells.PPAR Res. 2012;2012:929052. doi: 10.1155/2012/929052. Epub 2012 Feb 20. PPAR Res. 2012. PMID: 22448169 Free PMC article.
-
Peroxisome proliferator-activated receptor gamma regulates E-cadherin expression and inhibits growth and invasion of prostate cancer.Mol Cell Biol. 2006 Oct;26(20):7561-74. doi: 10.1128/MCB.00605-06. Mol Cell Biol. 2006. PMID: 17015477 Free PMC article.
-
4-O-methylhonokiol, a PPARγ agonist, inhibits prostate tumour growth: p21-mediated suppression of NF-κB activity.Br J Pharmacol. 2013 Mar;168(5):1133-45. doi: 10.1111/j.1476-5381.2012.02235.x. Br J Pharmacol. 2013. PMID: 23043610 Free PMC article.
-
A Role for the PPARgamma in Cancer Therapy.PPAR Res. 2008;2008:314974. doi: 10.1155/2008/314974. PPAR Res. 2008. PMID: 18528521 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous